Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), Madrid, Spain.
Unidad de Nanobiotecnología Asociada al Centro Nacional de Biotecnología (CSIC), Madrid, Spain.
Protein Sci. 2024 Jul;33(7):e5031. doi: 10.1002/pro.5031.
Proteins are constantly undergoing folding and unfolding transitions, with rates that determine their homeostasis in vivo and modulate their biological function. The ability to optimize these rates without affecting overall native stability is hence highly desirable for protein engineering and design. The great challenge is, however, that mutations generally affect folding and unfolding rates with inversely complementary fractions of the net free energy change they inflict on the native state. Here we address this challenge by targeting the folding transition state (FTS) of chymotrypsin inhibitor 2 (CI2), a very slow and stable two-state folding protein with an FTS known to be refractory to change by mutation. We first discovered that the CI2's FTS is energetically taxed by the desolvation of several, highly conserved, charges that form a buried salt bridge network in the native structure. Based on these findings, we designed a CI2 variant that bears just four mutations and aims to selectively stabilize the FTS. This variant has >250-fold faster rates in both directions and hence identical native stability, demonstrating the success of our FTS-centric design strategy. With an optimized FTS, CI2 also becomes 250-fold more sensitive to proteolytic degradation by its natural substrate chymotrypsin, and completely loses its activity as inhibitor. These results indicate that CI2 has been selected through evolution to have a very unstable FTS in order to attain the kinetic stability needed to effectively function as protease inhibitor. Moreover, the CI2 case showcases that protein (un)folding rates can critically pivot around a few key residues-interactions, which can strongly modify the general effects of known structural factors such as domain size and fold topology. From a practical standpoint, our results suggest that future efforts should perhaps focus on identifying such critical residues-interactions in proteins as best strategy to significantly improve our ability to predict and engineer protein (un)folding rates.
蛋白质不断经历折叠和展开的转变,其速率决定了它们在体内的内稳态,并调节它们的生物学功能。因此,能够在不影响整体天然稳定性的情况下优化这些速率,对于蛋白质工程和设计来说是非常理想的。然而,巨大的挑战是,突变通常会以相互补充的方式影响折叠和展开速率,从而改变它们对天然状态造成的净自由能变化。在这里,我们通过靶向糜蛋白酶抑制剂 2(CI2)的折叠转变态(FTS)来应对这一挑战,CI2 是一种非常缓慢且稳定的两态折叠蛋白,其 FTS 已知不易通过突变改变。我们首先发现,CI2 的 FTS 受到几个高度保守的电荷的去溶剂化的影响,这些电荷在天然结构中形成一个埋藏的盐桥网络。基于这些发现,我们设计了一个 CI2 变体,它只带有四个突变,旨在选择性地稳定 FTS。这个变体在两个方向上的速度都快了>250 倍,因此具有相同的天然稳定性,证明了我们以 FTS 为中心的设计策略的成功。通过优化 FTS,CI2 对其天然底物糜蛋白酶的蛋白水解降解的敏感性也提高了 250 倍,并且完全失去了作为抑制剂的活性。这些结果表明,CI2 是通过进化选择具有非常不稳定的 FTS 的,以获得有效作为蛋白酶抑制剂所需的动力学稳定性。此外,CI2 案例表明,蛋白质(解)折叠速率可以围绕几个关键残基相互作用关键枢轴,这可以强烈改变已知结构因素(如结构域大小和折叠拓扑)的一般影响。从实际的角度来看,我们的结果表明,未来的努力可能应该集中在确定蛋白质中的这些关键残基相互作用上,这是提高我们预测和设计蛋白质(解)折叠速率的能力的最佳策略。